Skip to Main content Skip to Navigation
Conference papers

SGLT2 inhibition by empagliflozin attenuates ectopic fat accumulation and improves cardiac index in parallel to ketone bodies production: the EMPAFAT study

F. Maurice P. Ancel E. Mayoux I. Abdesselam F. Kober 1 P. Darmon M. Grino B. Gaborit 1 M. Bernard 1 A. Dutour
1 CRMBM - Centre de résonance magnétique biologique et médicale
Document type :
Conference papers
Complete list of metadata
https://hal-amu.archives-ouvertes.fr/hal-01784725
Contributor : Monique Bernard Connect in order to contact the contributor
Submitted on : Thursday, May 3, 2018 - 4:57:09 PM
Last modification on : Wednesday, November 3, 2021 - 5:49:34 AM

Identifiers

  • HAL Id : hal-01784725, version 1

Collections

UNIV-AMU | CRMBM | CNRS

Citation

F. Maurice, P. Ancel, E. Mayoux, I. Abdesselam, F. Kober, et al.. SGLT2 inhibition by empagliflozin attenuates ectopic fat accumulation and improves cardiac index in parallel to ketone bodies production: the EMPAFAT study. 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD), EASD, Sep 2017, Lisbon, Portugal. pp.S414--S414. ⟨hal-01784725⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Les métriques sont temporairement indisponibles